A Study of Human Cytomegalovirus (HCMV) Vaccine SPYVLP01 With and Without Adjuvants

Clinical trial NCT06145178 · COMPLETED

Trial details

NCT number: NCT06145178
Sponsor: SpyBiotech Limited
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Cytomegalovirus Infections

Start date: 2023-11-22
Primary completion: 2025-06-20
Enrollment: 120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.